A study of more than 21,000 average risk patients at 186 sites across the U.S., led by Regenstrief Institute and Indiana University School of Medicine research scientist Thomas Imperiale, M.D., has ...
Noninvasive surveillance with multitarget stool DNA testing or fecal immunochemical testing (FIT) could potentially match colonoscopy for reducing long-term colorectal cancer (CRC) incidence and ...
Colorectal cancer continues to be one of the leading causes of cancer-related deaths worldwide. However, recent advancements in medical screening have brought new hope in the fight against this deadly ...
The U.S. Preventive Services Task Force recommends colorectal cancer screening for all adults starting at age 45. After age 75, the task force recommends talking with your health care team to decide ...
Roughly 10% of fecal immunochemical tests (FIT) used for colorectal cancer (CRC) screening by a safety-net health system contained unsatisfactory samples that could not be processed. And fewer than ...
A Lancashire man says a simple NHS bowel cancer test kit "saved my life" after it detected the disease before he had any ...
FIT outperformed cfDNA in detecting advanced precancerous colorectal lesions, showing higher sensitivity and specificity. Blood-based tests offer easier implementation and potentially higher adherence ...
See more Winnipeg Sun on Google - pleasesave as a Preferred Source ...
Q: My doctor always encourages me to do a colonoscopy for colorectal cancer screening. But I have friends who just do a stool test at home, which seems easier. Why should I go through the hassle of a ...
A noninvasive, multitarget stool RNA (mt-sRNA) test has high sensitivity for detecting colorectal neoplasia, according to a study published online Oct. 23 in the Journal of the American Medical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results